Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 118 entries
Sorted by: Best Match Show Resources per page
Students' reasoning about electricity: Combining performance assessments with argumentation analysis

Science education

Druker S, Kelly GJ.
GSID: yfUWv6lKwDgJ
GJ Kelly, S Druker, C Chen - International journal of science …, 1998 - Taylor & Francis

In this paper a set of methodological procedures to analyse students' arguments is presented. Normative perspectives from the philosophy of science and naturalistic …

Cite
Kelly, G. J., Druker, S., & Chen, C. (1998). Students’ reasoning about electricity: Combining performance assessments with argumentation analysis. International journal of science education, 20(7), 849-871.
Kelly, Gregory J., Stephen Druker, and Catherine Chen. "Students’ reasoning about electricity: Combining performance assessments with argumentation analysis." International journal of science education 20.7 (1998): 849-871.
Copy Download .nbib Format: MLA
Spatial probability AIDS visual stimulus discrimination.

Frontiers in human neuroscience

Druker M, Anderson B.
PMID: 20740078
Front Hum Neurosci. 2010 Aug 06;4. doi: 10.3389/fnhum.2010.00063. eCollection 2010.

We investigated whether the statistical predictability of a target's location would influence how quickly and accurately it was classified. Recent results have suggested that spatial probability can be a cue for the allocation of attention in visual search. One...

Cite
Druker M, Anderson B. Spatial probability AIDS visual stimulus discrimination. Front Hum Neurosci. 2010;4doi: 10.3389/fnhum.2010.00063.
Druker, M., & Anderson, B. (2010). Spatial probability AIDS visual stimulus discrimination. Frontiers in human neuroscience, 4. https://doi.org/10.3389/fnhum.2010.00063
Druker, Michael, and Anderson, Britt. "Spatial probability AIDS visual stimulus discrimination." Frontiers in human neuroscience vol. 4 (2010). doi: https://doi.org/10.3389/fnhum.2010.00063
Druker M, Anderson B. Spatial probability AIDS visual stimulus discrimination. Front Hum Neurosci. 2010 Aug 06;4. doi: 10.3389/fnhum.2010.00063. eCollection 2010. PMID: 20740078; PMCID: PMC2927278.
Copy Download .nbib Format: NLM
Guided VLS growth of epitaxial lateral Si nanowires.

Nano letters

Rathi SJ, Smith DJ, Drucker J.
PMID: 23899006
Nano Lett. 2013 Aug 14;13(8):3878-83. doi: 10.1021/nl401962q. Epub 2013 Aug 02.

Using the Au-seeded vapor-liquid-solid technique, epitaxial single-crystal Si nanowires (NWs) can be grown laterally along Si(111) substrates that have been miscut toward [112¯]. The ratio of lateral-to-vertical NWs increases as the miscut angle increases and as disilane pressure and...

Cite
Rathi SJ, Smith DJ, Drucker J. Guided VLS growth of epitaxial lateral Si nanowires. Nano Lett. 2013;13(8):3878-83doi: 10.1021/nl401962q.
Rathi, S. J., Smith, D. J., & Drucker, J. (2013). Guided VLS growth of epitaxial lateral Si nanowires. Nano letters, 13(8), 3878-83. https://doi.org/10.1021/nl401962q
Rathi, Somilkumar J, et al. "Guided VLS growth of epitaxial lateral Si nanowires." Nano letters vol. 13,8 (2013): 3878-83. doi: https://doi.org/10.1021/nl401962q
Rathi SJ, Smith DJ, Drucker J. Guided VLS growth of epitaxial lateral Si nanowires. Nano Lett. 2013 Aug 14;13(8):3878-83. doi: 10.1021/nl401962q. Epub 2013 Aug 02. PMID: 23899006.
Copy Download .nbib Format: NLM
Glucagon-like Peptide 2.

Trends in endocrinology and metabolism: TEM

Drucker DJ.
PMID: 10322410
Trends Endocrinol Metab. 1999 May;10(4):153-156. doi: 10.1016/s1043-2760(98)00136-2.

Glucagon-like peptide 2 (GLP-2) is secreted in a nutrient-dependent manner from enteroendocrine cells throughout the gastrointestinal tract and is trophic to the intestinal epithelial mucosa. GLP-2 acts via stimulation of crypt cell proliferation and inhibition of cell death. GLP-2...

Cite
Drucker DJ. Glucagon-like Peptide 2. Trends Endocrinol Metab. 1999;10(4):153-156doi: 10.1016/s1043-2760(98)00136-2.
Drucker, D. J. (1999). Glucagon-like Peptide 2. Trends in endocrinology and metabolism: TEM, 10(4), 153-156. https://doi.org/10.1016/s1043-2760(98)00136-2
Drucker. "Glucagon-like Peptide 2." Trends in endocrinology and metabolism: TEM vol. 10,4 (1999): 153-156. doi: https://doi.org/10.1016/s1043-2760(98)00136-2
Drucker DJ. Glucagon-like Peptide 2. Trends Endocrinol Metab. 1999 May;10(4):153-156. doi: 10.1016/s1043-2760(98)00136-2. PMID: 10322410.
Copy Download .nbib Format: NLM
Country profile. France.

Lancet (London, England)

Colin C, Geffroy L, Maisonneuve H, Ménard J, Guiraud-Chaumeil B, Fourquet F, Drucker J, Matillon Y, Goldberg J, Griscelli C.
PMID: 9074590
Lancet. 1997 Mar 15;349(9054):791-7. doi: 10.1016/s0140-6736(97)01388-3.

No abstract available.

Cite
Colin C, Geffroy L, Maisonneuve H, et al. Country profile. France. Lancet. 1997;349(9054):791-7doi: 10.1016/s0140-6736(97)01388-3.
Colin, C., Geffroy, L., Maisonneuve, H., Ménard, J., Guiraud-Chaumeil, B., Fourquet, F., Drucker, J., Matillon, Y., Goldberg, J., & Griscelli, C. (1997). Country profile. France. Lancet (London, England), 349(9054), 791-7. https://doi.org/10.1016/s0140-6736(97)01388-3
Colin, C, et al. "Country profile. France." Lancet (London, England) vol. 349,9054 (1997): 791-7. doi: https://doi.org/10.1016/s0140-6736(97)01388-3
Colin C, Geffroy L, Maisonneuve H, Ménard J, Guiraud-Chaumeil B, Fourquet F, Drucker J, Matillon Y, Goldberg J, Griscelli C. Country profile. France. Lancet. 1997 Mar 15;349(9054):791-7. doi: 10.1016/s0140-6736(97)01388-3. PMID: 9074590.
Copy Download .nbib Format: NLM
Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation.

Endocrine reviews

McLean BA, Wong CK, Campbell JE, Hodson DJ, Trapp S, Drucker DJ.
PMID: 33320179
Endocr Rev. 2021 Mar 15;42(2):101-132. doi: 10.1210/endrev/bnaa032.

Glucagon-like peptide-1 (GLP-1) is produced in gut endocrine cells and in the brain, and acts through hormonal and neural pathways to regulate islet function, satiety, and gut motility, supporting development of GLP-1 receptor (GLP-1R) agonists for the treatment of...

Cite
McLean BA, Wong CK, Campbell JE, et al. Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation. Endocr Rev. 2021;42(2):101-132doi: 10.1210/endrev/bnaa032.
McLean, B. A., Wong, C. K., Campbell, J. E., Hodson, D. J., Trapp, S., & Drucker, D. J. (2021). Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation. Endocrine reviews, 42(2), 101-132. https://doi.org/10.1210/endrev/bnaa032
McLean, Brent A, et al. "Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation." Endocrine reviews vol. 42,2 (2021): 101-132. doi: https://doi.org/10.1210/endrev/bnaa032
McLean BA, Wong CK, Campbell JE, Hodson DJ, Trapp S, Drucker DJ. Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation. Endocr Rev. 2021 Mar 15;42(2):101-132. doi: 10.1210/endrev/bnaa032. PMID: 33320179; PMCID: PMC7958144.
Copy Download .nbib Format: NLM
The gut microbiota regulates hypothalamic inflammation and leptin sensitivity in Western diet-fed mice via a GLP-1R-dependent mechanism.

Cell reports

Heiss CN, Mannerås-Holm L, Lee YS, Serrano-Lobo J, Håkansson Gladh A, Seeley RJ, Drucker DJ, Bäckhed F, Olofsson LE.
PMID: 34038733
Cell Rep. 2021 May 25;35(8):109163. doi: 10.1016/j.celrep.2021.109163.

Mice lacking a microbiota are protected from diet-induced obesity. Previous studies have shown that feeding a Western diet causes hypothalamic inflammation, which in turn can lead to leptin resistance and weight gain. Here, we show that wild-type (WT) mice...

Cite
Heiss CN, Mannerås-Holm L, Lee YS, et al. The gut microbiota regulates hypothalamic inflammation and leptin sensitivity in Western diet-fed mice via a GLP-1R-dependent mechanism. Cell Rep. 2021;35(8):109163doi: 10.1016/j.celrep.2021.109163.
Heiss, C. N., Mannerås-Holm, L., Lee, Y. S., Serrano-Lobo, J., Håkansson Gladh, A., Seeley, R. J., Drucker, D. J., Bäckhed, F., & Olofsson, L. E. (2021). The gut microbiota regulates hypothalamic inflammation and leptin sensitivity in Western diet-fed mice via a GLP-1R-dependent mechanism. Cell reports, 35(8), 109163. https://doi.org/10.1016/j.celrep.2021.109163
Heiss, Christina N, et al. "The gut microbiota regulates hypothalamic inflammation and leptin sensitivity in Western diet-fed mice via a GLP-1R-dependent mechanism." Cell reports vol. 35,8 (2021): 109163. doi: https://doi.org/10.1016/j.celrep.2021.109163
Heiss CN, Mannerås-Holm L, Lee YS, Serrano-Lobo J, Håkansson Gladh A, Seeley RJ, Drucker DJ, Bäckhed F, Olofsson LE. The gut microbiota regulates hypothalamic inflammation and leptin sensitivity in Western diet-fed mice via a GLP-1R-dependent mechanism. Cell Rep. 2021 May 25;35(8):109163. doi: 10.1016/j.celrep.2021.109163. PMID: 34038733.
Copy Download .nbib Format: NLM
The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome.

ACS pharmacology & translational science

Drucker DJ.
PMID: 32219218
ACS Pharmacol Transl Sci. 2019 Mar 01;2(2):134-142. doi: 10.1021/acsptsci.9b00016. eCollection 2019 Apr 12.

The proglucagon gene encodes multiple structurally related peptides with overlapping actions promoting the absorption and assimilation of ingested energy. Notably, glucagon has been developed pharmaceutically to treat hypoglycemia, and glucagon-like peptide-1 (GLP-1) receptor agonists are used for the therapy...

Cite
Drucker DJ. The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome. ACS Pharmacol Transl Sci. 2019;2(2):134-142doi: 10.1021/acsptsci.9b00016.
Drucker, D. J. (2019). The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome. ACS pharmacology & translational science, 2(2), 134-142. https://doi.org/10.1021/acsptsci.9b00016
Drucker, Daniel J. "The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome." ACS pharmacology & translational science vol. 2,2 (2019): 134-142. doi: https://doi.org/10.1021/acsptsci.9b00016
Drucker DJ. The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome. ACS Pharmacol Transl Sci. 2019 Mar 01;2(2):134-142. doi: 10.1021/acsptsci.9b00016. eCollection 2019 Apr 12. PMID: 32219218; PMCID: PMC7088900.
Copy Download .nbib Format: NLM
Pulse-to-pulse wavefront sensing at free-electron lasers using ptychography.

Journal of applied crystallography

Sala S, Daurer BJ, Odstrcil M, Capotondi F, Pedersoli E, Hantke MF, Manfredda M, Loh ND, Thibault P, Maia FRNC.
PMID: 32788902
J Appl Crystallogr. 2020 Jul 08;53:949-956. doi: 10.1107/S1600576720006913. eCollection 2020 Aug 01.

The pressing need for knowledge of the detailed wavefront properties of ultra-bright and ultra-short pulses produced by free-electron lasers has spurred the development of several complementary characterization approaches. Here a method based on ptychography is presented that can retrieve...

Cite
Sala S, Daurer BJ, Odstrcil M, et al. Pulse-to-pulse wavefront sensing at free-electron lasers using ptychography. J Appl Crystallogr. 2020;53:949-956doi: 10.1107/S1600576720006913.
Sala, S., Daurer, B. J., Odstrcil, M., Capotondi, F., Pedersoli, E., Hantke, M. F., Manfredda, M., Loh, N. D., Thibault, P., & Maia, F. R. N. C. (2020). Pulse-to-pulse wavefront sensing at free-electron lasers using ptychography. Journal of applied crystallography, 53949-956. https://doi.org/10.1107/S1600576720006913
Sala, Simone, et al. "Pulse-to-pulse wavefront sensing at free-electron lasers using ptychography." Journal of applied crystallography vol. 53 (2020): 949-956. doi: https://doi.org/10.1107/S1600576720006913
Sala S, Daurer BJ, Odstrcil M, Capotondi F, Pedersoli E, Hantke MF, Manfredda M, Loh ND, Thibault P, Maia FRNC. Pulse-to-pulse wavefront sensing at free-electron lasers using ptychography. J Appl Crystallogr. 2020 Jul 08;53:949-956. doi: 10.1107/S1600576720006913. eCollection 2020 Aug 01. PMID: 32788902; PMCID: PMC7401787.
Copy Download .nbib Format: NLM
Tumor surveillance for children and adolescents with cancer predisposition syndromes: The psychosocial impact reported by adolescents and caregivers.

Pediatric blood & cancer

van Engelen K, Barrera M, Wasserman JD, Armel SR, Chitayat D, Druker H, Gallinger B, Malkin D, Villani A.
PMID: 33788392
Pediatr Blood Cancer. 2021 Aug;68(8):e29021. doi: 10.1002/pbc.29021. Epub 2021 Mar 31.

PURPOSE: Individuals with cancer predisposition syndromes (CPS) are often followed in cancer screening programs, which aim to detect early stage tumors. While cancer surveillance has the potential to improve patient outcomes, its psychosocial impact is uncharacterized in the pediatric...

Cite
van Engelen K, Barrera M, Wasserman JD, et al. Tumor surveillance for children and adolescents with cancer predisposition syndromes: The psychosocial impact reported by adolescents and caregivers. Pediatr Blood Cancer. 2021;68(8):e29021doi: 10.1002/pbc.29021.
van Engelen, K., Barrera, M., Wasserman, J. D., Armel, S. R., Chitayat, D., Druker, H., Gallinger, B., Malkin, D., & Villani, A. (2021). Tumor surveillance for children and adolescents with cancer predisposition syndromes: The psychosocial impact reported by adolescents and caregivers. Pediatric blood & cancer, 68(8), e29021. https://doi.org/10.1002/pbc.29021
van Engelen, Kalene, et al. "Tumor surveillance for children and adolescents with cancer predisposition syndromes: The psychosocial impact reported by adolescents and caregivers." Pediatric blood & cancer vol. 68,8 (2021): e29021. doi: https://doi.org/10.1002/pbc.29021
van Engelen K, Barrera M, Wasserman JD, Armel SR, Chitayat D, Druker H, Gallinger B, Malkin D, Villani A. Tumor surveillance for children and adolescents with cancer predisposition syndromes: The psychosocial impact reported by adolescents and caregivers. Pediatr Blood Cancer. 2021 Aug;68(8):e29021. doi: 10.1002/pbc.29021. Epub 2021 Mar 31. PMID: 33788392.
Copy Download .nbib Format: NLM
NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia.

Investigational new drugs

Scopim-Ribeiro R, Machado-Neto JA, Eide CA, Coelho-Silva JL, Fenerich BA, Fernandes JC, Scheucher PS, Savage Stevens SL, de Melo Campos P, Olalla Saad ST, de Carvalho Palma L, de Figueiredo-Pontes LL, Simões BP, Rego EM, Tognon CE, Druker BJ, Traina F.
PMID: 33403501
Invest New Drugs. 2021 Jun;39(3):736-746. doi: 10.1007/s10637-020-01028-8. Epub 2021 Jan 06.

Chronic myeloid leukemia (CML) is successfully treated with BCR-ABL1 tyrosine kinase inhibitors, but a significant percentage of patients develop resistance. Insulin receptor substrate 1 (IRS1) has been shown to constitutively associate with BCR-ABL1, and IRS1-specific silencing leads to antineoplastic...

Cite
Scopim-Ribeiro R, Machado-Neto JA, Eide CA, et al. NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia. Invest New Drugs. 2021;39(3):736-746doi: 10.1007/s10637-020-01028-8.
Scopim-Ribeiro, R., Machado-Neto, J. A., Eide, C. A., Coelho-Silva, J. L., Fenerich, B. A., Fernandes, J. C., Scheucher, P. S., Savage Stevens, S. L., de Melo Campos, P., Olalla Saad, S. T., de Carvalho Palma, L., de Figueiredo-Pontes, L. L., Simões, B. P., Rego, E. M., Tognon, C. E., Druker, B. J., & Traina, F. (2021). NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia. Investigational new drugs, 39(3), 736-746. https://doi.org/10.1007/s10637-020-01028-8
Scopim-Ribeiro, Renata, et al. "NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia." Investigational new drugs vol. 39,3 (2021): 736-746. doi: https://doi.org/10.1007/s10637-020-01028-8
Scopim-Ribeiro R, Machado-Neto JA, Eide CA, Coelho-Silva JL, Fenerich BA, Fernandes JC, Scheucher PS, Savage Stevens SL, de Melo Campos P, Olalla Saad ST, de Carvalho Palma L, de Figueiredo-Pontes LL, Simões BP, Rego EM, Tognon CE, Druker BJ, Traina F. NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia. Invest New Drugs. 2021 Jun;39(3):736-746. doi: 10.1007/s10637-020-01028-8. Epub 2021 Jan 06. PMID: 33403501.
Copy Download .nbib Format: NLM
DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia.

Genome research

Giacopelli B, Wang M, Cleary A, Wu YZ, Schultz AR, Schmutz M, Blachly JS, Eisfeld AK, Mundy-Bosse B, Vosberg S, Greif PA, Claus R, Bullinger L, Garzon R, Coombes KR, Bloomfield CD, Druker BJ, Tyner JW, Byrd JC, Oakes CC.
PMID: 33707228
Genome Res. 2021 May;31(5):747-761. doi: 10.1101/gr.269233.120. Epub 2021 Mar 11.

Acute myeloid leukemia (AML) is a molecularly complex disease characterized by heterogeneous tumor genetic profiles and involving numerous pathogenic mechanisms and pathways. Integration of molecular data types across multiple patient cohorts may advance current genetic approaches for improved subclassification...

Cite
Giacopelli B, Wang M, Cleary A, et al. DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia. Genome Res. 2021;31(5):747-761doi: 10.1101/gr.269233.120.
Giacopelli, B., Wang, M., Cleary, A., Wu, Y. Z., Schultz, A. R., Schmutz, M., Blachly, J. S., Eisfeld, A. K., Mundy-Bosse, B., Vosberg, S., Greif, P. A., Claus, R., Bullinger, L., Garzon, R., Coombes, K. R., Bloomfield, C. D., Druker, B. J., Tyner, J. W., Byrd, J. C., & Oakes, C. C. (2021). DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia. Genome research, 31(5), 747-761. https://doi.org/10.1101/gr.269233.120
Giacopelli, Brian, et al. "DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia." Genome research vol. 31,5 (2021): 747-761. doi: https://doi.org/10.1101/gr.269233.120
Giacopelli B, Wang M, Cleary A, Wu YZ, Schultz AR, Schmutz M, Blachly JS, Eisfeld AK, Mundy-Bosse B, Vosberg S, Greif PA, Claus R, Bullinger L, Garzon R, Coombes KR, Bloomfield CD, Druker BJ, Tyner JW, Byrd JC, Oakes CC. DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia. Genome Res. 2021 May;31(5):747-761. doi: 10.1101/gr.269233.120. Epub 2021 Mar 11. PMID: 33707228; PMCID: PMC8092005.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 118 entries